Ernexa Therapeutics logo

Ernexa Therapeutics

ERNA | NASDAQ
Chart Builder DCF Calculator
$1.69
+$0.01 (+0.60%)
At close: Nov 16, 2026, 4:00 PM ET
$1.68
-$0.01 (-0.59%)
After-hours: Nov 16, 2026, 5:58 PM ET
+0.60%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
30.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #792/1021 (Top 78%)

Key Statistics

Market Data

Market Cap $2.86M
1D Range
1.66 1.81
52W Range
1.66 37.75

Valuation (TTM)

PE -0.10
PB 0.66
EV/EBITDA 0.13

Valuation (NTM)

Forward PE N/A
Forward PEG 0.00
Price Target $0.00
Loading financial charts...

Profile

Ernexa Therapeutics Inc. is a biotechnology firm currently in its preclinical development phase, specializing in the creation of therapeutic interventions using induced mesenchymal stem cells (iMSCs)....

Sector Healthcare
Industry Biotechnology
Employees 5
IPO Date Aug 29, 1991
Fiscal Year January - December

Latest News

No news articles available yet.

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.